Skip to content

Vigadrone

Published: July 26, 2026Updated: August 26, 2026

Vigadrone is a prescription anticonvulsant medication used to treat infantile spasms in children and as an adjunctive treatment for refractory complex partial seizures in adults when other therapies have not been effective. It works by increasing levels of GABA, a calming neurotransmitter in the brain, which helps reduce seizure activity. Due to the risk of permanent vision loss, this medication is only available through a restricted distribution program.

Quick summary

Vigadrone is an anticonvulsant used primarily for infantile spasms and refractory seizures, requiring close monitoring due to risk of permanent vision loss.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 26, 2026Editorial policy

Key facts at a glance

RxNorm
2047863
Generic
Vigadrone
Class
brand-name
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Treatment of infantile spasms in infants and children 1 month to 2 years old, and as adjunctive therapy for refractory complex partial seizures in adults when other antiepileptic drugs have not provided adequate seizure control.

Vigadrone works by irreversibly inhibiting GABA transaminase, an enzyme that breaks down GABA (gamma-aminobutyric acid). This increases GABA levels in the brain, enhancing inhibitory signaling and reducing neuronal excitability that leads to seizures.

May cause permanent peripheral vision loss that can be severe; regular ophthalmologic monitoring is required. Can cause drowsiness, fatigue, and weight gain. Should not be discontinued abruptly as this may increase seizure frequency. Available only through a restricted REMS program due to safety concerns.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy